A major pro-inflammatory cytokine produced primarily by macrophages. Central to initiating and sustaining inflammatory responses, it is a key target of both the cholinergic anti-inflammatory pathway and several widely used anti-inflammatory drug therapies.
TNF-α is among the most intensively studied cytokines in immunology. Released rapidly by macrophages in response to infection or immune activation, its effects include fever, recruitment of other immune cells, and amplification of local inflammation.
Chronic or excessive TNF-α production is associated with septic shock, rheumatoid arthritis, psoriasis, Crohn's disease, and other autoimmune conditions. TNF-α inhibitors such as adalimumab and etanercept are widely used treatments for these diseases.
The vagus nerve's cholinergic anti-inflammatory pathway suppresses TNF-α release from macrophages through acetylcholine–α7 nAChR signaling. TNF-α was the first cytokine identified in this pathway in Kevin Tracey's foundational research on the inflammatory reflex.